NeuroTrials.ai
🔍 Keywords and Filters Collapse (–)
Thrombolysis:
tPA
TNK
Reteplase
Extended Window
Intra-arterial
Skip-IVT
Thrombectomy:
LVO
Distal/MeVO
Basilar
Large Core
Extended-window
Tandem
Adjuvants:
Adjuvant
BP-Control
Neuroprotection
Rehab:
Rehab
VNS
DBS
tcDCS
Cardioembolic:
Afib
AHRE/SCAF
Low EF
LAAO
PFO
Large Artery:
Carotid-Stenosis
Vertebral
ICAD
SVD Risk:
HTN
DM
HLD
OSA
Other Causes:
ESUS
Dissection
APLS
Hormonal
Drugs:
DAPT
DOACs
Dual-Therapy
Statins
GLP1
Other
Other:
Primary Prevention
CVT
Pediatric
Cancer
Hemorrhagic:
ICH
SAH
SDH
Year:
2025
2024
2023
2022
2021
2020
Older
Triptans:
Triptans
Sumatriptan
Rizatriptan
Zolmitriptan
Eletriptan
Almotriptan
Naratriptan
Frovatriptan
CGRP:
CGRPs
Ubrogepant
Rimegepant
Atogepant
Zavegepant
Erenumab
Galcanezumab
Fremanezumab
Others:
Lasmiditan
Beta Blockers
AEDs
TCAs
SNRIs
Botox
Nerve Blocks
Devices
Neuromodulation
Primary:
Migraine
Tension
NDPH
TACs:
Cluster
SUNCT/SUNA
Trigeminal Neuralgia
Other Conditions:
MOH
Post-traumatic
SIH
GCA
Chronic Migraine
Aura & Others:
Aura
Biomarkers
Pediatric
Seizure Types:
Focal
Generalized
Absence
Tonic-Clonic
Atonic
Syndromes:
Lennox-Gastaut
Dravet
JME
TLE
FLE
Causes:
Genetic
Structural
Metabolic
Autoimmune
Medications (AEDs):
Levetiracetam
Brivaracetam
Lacosamide
Perampanel
Clobazam
Eslicarbazepine
Topiramate
Zonisamide
Lamotrigine
Oxcarbazepine
Carbamazepine
Valproate
CBD
Surgery & Devices:
Epilepsy Surgery
VNS
DBS
RNS
Other Therapies:
Ketogenic Diet
Status Epilepticus
Diagnostics:
EEG
MRI
MEG
Wearable Devices
Biomarkers
Parkinsonism:
Parkinson’s Disease (PD)
Atypical Parkinsonism
MSA
PSP
CBD
DIP
Hyperkinetic:
Huntington’s Disease
Dystonia
Tremor
Chorea
Tics/Tourette’s
Ataxia
RLS
Myoclonus
Pharmacologic:
Levodopa
Dopamine Agonists
Ropinirole
Pramipexole
Apomorphine
MAO-B Inhibitors
Amantadine
COMT Inhibitors
A2A Antagonists
Surgical/Device:
DBS
FUS
Lesioning
Botulinum Toxin
Other Therapies:
Gene Therapy
Stem Cell Therapy
Physical Therapy
Motor & Other:
Dyskinesia
Motor Fluctuations
Gait Instability
Cognitive Impairment
Sleep Disorders (RBD, PLM)
Non-Motor Symptoms
Types:
Alzheimer’s
Lewy Body
FTD
VaD
Parkinson’s Dementia
Mixed
Rapidly Progressive
Treatment:
DMT
Aducanumab
Lecanemab
Donanemab
Donepezil
Rivastigmine
Galantamine
Memantine
Symptomatic:
Agitation
Psychosis
Depression
Apathy
Gait
REM Behavior Disorder
Diagnostic:
CSF Biomarkers
Plasma Biomarkers
Amyloid/Tau PET
MRI
FDG-PET
MMSE
MoCA
| Trial Name | Year | Objective | Summary |
|---|---|---|---|
| Loading… | |||
NeuroTrials.ai